p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL
Eμ-TCL1 小鼠模型中，p53 独立的伊布替尼反应证实其对高风险 CLL 有效
期刊:Blood Cancer Journal
影响因子:12.9
doi:10.1038/bcj.2016.41
H J Lee, M Gallardo, H Ma, X Zhang, C A Larsson, A Mejia, M J Hornbaker, Y Qi, X Su, L R Pageon, A Quintas-Cardama, S M Post
